Quince Therapeutics, Inc. (QNCX) — DEF 14A Filings
All DEF 14A filings from Quince Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Quince Therapeutics Files DEF 14A on Executive Compensation
— Apr 23, 2025 Risk: low
Quince Therapeutics, Inc. filed a DEF 14A on April 23, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes -
Quince Therapeutics, Inc. Files Definitive Proxy Statement (DEF 14A)
— Apr 24, 2024 Risk: low
Quince Therapeutics, Inc. (QNCX) filed a Proxy Statement (DEF 14A) with the SEC on April 24, 2024. Quince Therapeutics, Inc. (formerly Cortexyme, Inc.) filed a
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX